FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma By Ogkologos - May 20, 2026 113 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for safety and efficacy is based on the findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Selumetinib Approved by FDA to Treat Children with NF1 April 14, 2020 FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory B-Cell Precursor Acute... October 7, 2021 Truck Driver Saves People From Bus Fire On Christmas Eve December 31, 2021 Shaping Future Oncology Leaders: ESMO Broadens Its Career Development Opportunities March 6, 2026 Load more HOT NEWS Terminally Ill ‘Flamingo Lady’ Gets Emotional After Dying Wish Comes True EMA Recommends Extension of Indications for Selpercatinib People with Intellectual Disability at Increased Risk of Cancer Junk food marketing restrictions: so near and yet so far
